Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
36.70B | 37.39B | 33.14B | 37.07B | 36.21B | 30.26B | Gross Profit |
10.37B | 10.68B | 8.09B | 9.44B | 8.76B | 6.77B | EBIT |
3.02B | 3.35B | 1.08B | 2.62B | 1.75B | -97.00M | EBITDA |
3.39B | 5.18B | 1.60B | 3.05B | 2.24B | 302.00M | Net Income Common Stockholders |
3.28B | 3.43B | 767.00M | 1.76B | 981.00M | -28.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
21.16B | 22.29B | 16.66B | 20.68B | 19.48B | 18.48B | Total Assets |
48.40B | 49.81B | 45.03B | 43.89B | 43.48B | 41.31B | Total Debt |
3.52B | 3.52B | 3.52B | 3.52B | 3.52B | 3.52B | Net Debt |
-17.64B | -18.77B | -13.14B | -17.16B | -15.97B | -14.96B | Total Liabilities |
14.99B | 15.84B | 14.83B | 15.20B | 16.46B | 14.28B | Stockholders Equity |
33.41B | 33.97B | 30.20B | 28.70B | 27.02B | 27.03B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.12B | -725.00M | 1.34B | 1.90B | -1.05B | Operating Cash Flow |
0.00 | 3.33B | -322.00M | 1.59B | 2.60B | -689.00M | Investing Cash Flow |
0.00 | 2.33B | -3.37B | -10.00M | -904.00M | -612.00M | Financing Cash Flow |
0.00 | -434.00M | -324.00M | -390.00M | -594.00M | -591.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥11.69B | 3.41 | 1.40% | 12.83% | 347.44% | ||
78 Outperform | ¥10.34B | 12.24 | 2.58% | 19.85% | 78.11% | ||
72 Outperform | ¥9.10B | 5.13 | 3.92% | -2.30% | 16.50% | ||
70 Outperform | ¥6.77B | 11.00 | 3.15% | 0.78% | 106.93% | ||
68 Neutral | ¥16.50B | 25.73 | 1.60% | 26.93% | 35.46% | ||
64 Neutral | ¥11.89B | 18.96 | 1.85% | 8.01% | 28.29% | ||
62 Neutral | $6.80B | 11.04 | 2.79% | 4.42% | 2.67% | -25.07% |